SPDR Dow Jones Industrial Average ETF

SPDR S&P 500 ETF Trust

Invesco QQQ Trust Series 1

SSgA Active Trust - State Street SPDR S&P 500 ETF Trust

SPY is experiencing heightened volatility as market participants weigh geopolitical instability in the Middle East against shifting inflationary expectations. Traders are actively debating whether the ongoing energy sector tensions and rhetoric surrounding potential infrastructure impacts will lead to a broader market correction or serve as a buying opportunity for dip-buyers.

T-Mobile US, Inc. engages in the provision of wireless communications services under the T-Mobile and MetroPCS brands. It offers postpaid and prepaid wireless voice, messaging and data services, and wholesale wireless services. The company was founded in 1994 and is headquartered in Bellevue, WA.

T-Mobile US Inc

T-Mobile US is capturing market attention as investors weigh its competitive positioning in 5G and satellite integration against broader sector-wide pricing pressures and technical consolidation. While some community members remain focused on long-term growth potential and recent institutional accumulation, others are debating the impact of increased industry competition on its forward performance.

SPDR Gold Trust - SPDR Gold Shares

SPDR Gold Shares ETF

SPDR Gold Shares (GLD) is experiencing a sharp, volatile sell-off, with investors debating whether this price action represents a temporary liquidity-driven liquidation or a fundamental breakdown of gold's safe-haven narrative. The community is actively discussing the impact of hotter-than-expected producer inflation data, a surging US dollar, and rising yields, while others treat the dip as a strategic opportunity to accumulate physical metal amidst ongoing geopolitical uncertainty.

ProShares Trust - ProShares UltraShort Bloomberg Natural Gas -2x Shares

ProShares UltraShort Bloomberg Natural Gas

KOLD is trending as investors weigh volatile geopolitical risks in the Middle East against bearish seasonal fundamentals like rising production and the approaching shoulder season. The community is actively debating whether ongoing tensions and potential maritime disruptions will provide a lasting floor for prices or if the expected inventory builds will ultimately drive a sharp downward reversal.

Robinhood Markets, Inc is a financial services platform, which engages in the provision of retail brokerage and offers trading in U.S. listed stocks and Exchange Traded Funds, related options, and cryptocurrency trading, as well as cash management, which includes debit cards services. The company was founded by Vladimir Tenev and Baiju Prafulkumar Bhatt in 2013 and is headquartered in Menlo Park, CA.

Robinhood Markets Inc - Ordinary Shares - Class A

Robinhood Markets Inc

Robinhood (HOOD) is trending as investors debate the stock's long-term potential following a significant correction and its heavy correlation with crypto market volatility. While some community members see the current price as a value opportunity supported by new product rollouts like social trading, others are concerned by regulatory headlines and the stock's persistent weakness compared to broader market indices.

ProShares Trust - ProShares Ultra Bloomberg Natural Gas 2x Shares

ProShares Ultra Bloomberg Natural Gas

ProShares Ultra Bloomberg Natural Gas is experiencing intense volatility and community debate as traders weigh the impact of Middle East geopolitical tensions against bearish seasonal trends and concerns over market manipulation. Investors are actively discussing the decoupling of U.S. natural gas from international price surges, with many debating whether the current price action reflects genuine supply disruptions or represents a temporary reaction to rhetoric regarding the Strait of Hormuz.

Invesco QQQ Trust Series 1 - Invesco QQQ Trust Series 1

The Invesco QQQ Trust is experiencing significant volatility as market participants weigh conflicting signals regarding the escalation of the conflict with Iran against potential diplomatic de-escalation efforts. Community sentiment is deeply divided, with traders closely monitoring the Strait of Hormuz, energy prices, and geopolitical headlines for cues on whether to brace for a broader market correction or position for a recovery.

Direxion Shares ETF Trust - Direxion Daily S&P Biotech Bull 3X ETF

Direxion Daily S&P Biotech Bull 3X Shares

LABU is currently trending as biotech investors capitalize on aggressive market rotation and increased speculative interest fueled by anticipation of further rate cuts and sector-specific buyout activity. Market participants are actively debating whether this rapid momentum represents a sustainable breakout or an overextended rally, leading to high-volume trading and significant volatility in leveraged biotech instruments.

Direxion Shares ETF Trust - Direxion Daily S&P Biotech Bear 3X ETF

Direxion Daily S&P Biotech Bear 3X Shares

Biotech remains a resilient outlier as investors rotate capital into the sector, leaving holders of this leveraged inverse ETF frustrated by persistent decoupling from broader market downturns. The community is actively debating the sustainability of this rotation and weighing entry points for a potential reversal, with many closely watching upcoming macroeconomic catalysts and sector-specific news to gauge if a long-overdue correction is finally approaching.

Enphase Energy, Inc. is a global energy technology company, which engages in the business of designing, developing, manufacturing, and selling home energy solutions that manage energy generation, energy storage, control, and communications on one intelligent platform. It operates through the following geographical segments: the United States, the Netherlands, and Others. The company was founded by Raghuveer R. Belur and Martin Fornage in March 2006 and is headquartered in Fremont, CA.

Enphase Energy Inc

Enphase Energy is surging following a strong quarterly earnings report that beat expectations, signaling a potential turnaround for the stock and triggering a significant short squeeze. Community sentiment is shifting toward bullish as traders highlight the company's resilient product demand, strategic growth in data center and grid storage markets, and improved guidance that has prompted a wave of analyst upgrades.

statis crypto Watchlist

Bitcoin

Ethereum

Solana

Ripple

Dogecoin

Cardano

statis IN Watchlist

Nifty 50

Nifty Bank

Reliance Industries Ltd.

Zomato Ltd.

Tata Consultancy Services

Tata Motors Ltd.

HDFC Bank Ltd.

ITC Ltd.

Adani Enterprises Ltd

Axis Bank Ltd

Bajaj Finance Ltd

statis US Watchlist

SPDR S&P 500 ETF

Apple Inc.

Tesla Inc

Microsoft Corporation

NVIDIA Corp

 Hey, I want to invite you to join Stocktwits. It’s the largest global community of active traders. You’ll get access to the real-time market insights, news, discussion and much more! You can sign up using my unique link below 
 


 has invited you to join Stocktwits

Acrivon Therapeutics, Inc. (NASDAQ:ACRV) Receives Average Recommendation of "Moderate Buy" from Analysts

Acrivon Therapeutics, Inc. (NASDAQ:ACRV - Get Free Report) has been given a consensus rating of "Moderate Buy" by the seven analysts that are currently covering the firm, Marketbeat Ratings reports. One equities research analyst has rated the stock with a sell rating, one has issued a hold ratin...

Acrivon Therapeutics (NASDAQ:ACRV) Releases Earnings Results, Meets Estimates

Acrivon Therapeutics (NASDAQ:ACRV - Get Free Report) released its quarterly earnings data on Thursday. The company reported ($0.49) earnings per share (EPS) for the quarter, meeting the consensus...

Acrivon Therapeutics (ACRV) Projected to Post Earnings on Thursday

Acrivon Therapeutics (NASDAQ:ACRV) will be releasing its Q4 2025 earnings before the market opens on Thursday, March 26. (View Earnings Report at https://www.marketbeat.com/earnings/reports/2026-3-26-acrivon-therapeutics-inc-stock...

Acrivon Therapeutics, Inc. (ACRV) Upgraded to Buy: Here's Why

Acrivon Therapeutics, Inc. (ACRV) might move higher on growing optimism about its earnings prospects, which is reflected by its upgrade to a Zacks Rank #2 (Buy).

Acrivon Therapeutics Conference Highlights ACR-368 Phase 2B Data, 52% ORR in Serous Endometrial Cancer

Acrivon Therapeutics (NASDAQ:ACRV) hosted a webcast featuring a key opinion leader (KOL) panel focused on the company's ongoing ACR-368 registrational-intent Phase 2B study in endometrial cancer...

Acrivon Therapeutics, Inc. (NASDAQ:ACRV) Sees Large Drop in Short Interest

Acrivon Therapeutics, Inc. (NASDAQ:ACRV - Get Free Report) was the recipient of a significant drop in short interest in January. As of January 30th, there was short interest totaling 2,024,627...

Acrivon Therapeutics, Inc. (NASDAQ:ACRV) Sees Large Increase in Short Interest

Acrivon Therapeutics, Inc. (NASDAQ:ACRV - Get Free Report) was the target of a large growth in short interest in January. As of January 15th, there was short interest totaling 7,521,144 shares, a...

Acrivon Therapeutics, Inc. (NASDAQ:ACRV) Given Average Rating of "Moderate Buy" by Brokerages

Shares of Acrivon Therapeutics, Inc. (NASDAQ:ACRV - Get Free Report) have received a consensus rating of "Moderate Buy" from the seven analysts that are presently covering the company, MarketBeat.com...

Adam Levy Acquires 8,832 Shares of Acrivon Therapeutics (NASDAQ:ACRV) Stock

Acrivon Therapeutics, Inc. (NASDAQ:ACRV - Get Free Report) CFO Adam Levy bought 8,832 shares of the company's stock in a transaction on Wednesday, January 14th. The shares were acquired at an average...

Acrivon Therapeutics (NASDAQ:ACRV) CFO Adam Levy Acquires 8,832 Shares

Acrivon Therapeutics, Inc. (NASDAQ:ACRV - Get Free Report) CFO Adam Levy bought 8,832 shares of the firm's stock in a transaction on Wednesday, January 14th. The stock was bought at an average price...

Acrivon Therapeutics, Inc. develops drugs for clinical treatment. Its unique precision medicine platform is Acrivon Predictive Precision Proteomics (AP3). AP3 is used to generate proprietary OncoSignature companion diagnostics to identify patients who will benefit from the medicine. The company was founded by Peter Blume-Jensen and Kristina Masson in 2018 and is headquartered in Watertown, MA.

Current Price	$1.66
Prev Close	$1.70
Open	$1.69
Dividend Yield	0.00%
50-Day Moving Average	$1.71
Beta	1.57
Avg. Volume	884,471.71
PE Ratio	-0.82

52-Week High	$5.65
52-Week Low	$1.05
Market Capitalization	$64.32M
EPS (Annual)	-$2.02
Price to Book	0.47
Revenue Per Employee	$0.00

ACRV
ACRIVON THERAPEUTICS INC

Feed

News

Sentiment

Earnings

Fundamentals

Info

Latest ACRV News

ACRVACRIVON THERAPEUTICS INC